vs

Side-by-side financial comparison of Fastly, Inc. (FSLY) and MADRIGAL PHARMACEUTICALS, INC. (MDGL). Click either name above to swap in a different company.

MADRIGAL PHARMACEUTICALS, INC. is the larger business by last-quarter revenue ($321.1M vs $172.6M, roughly 1.9× Fastly, Inc.). Fastly, Inc. runs the higher net margin — -9.0% vs -18.2%, a 9.3% gap on every dollar of revenue. On growth, MADRIGAL PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (210.8% vs 22.8%). Fastly, Inc. produced more free cash flow last quarter ($12.2M vs $-133.8M).

Fastly, Inc. is an American company based in San Francisco, which describes itself as a cloud computing company. Fastly provides content delivery network services, image optimization, and load balancing services. Fastly's cloud security services include denial-of-service attack protection, bot mitigation, and a web application firewall.

Intercept Pharmaceuticals, Inc. is an American biopharmaceutical company incorporated in 2002, focusing on the development of novel synthetic bile acid analogs to treat chronic liver diseases, such as primary biliary cirrhosis (PBC) now called primary biliary cholangitis, non-alcoholic fatty liver disease, cirrhosis, portal hypertension, primary sclerosing cholangitis and also the intestinal disorder, bile acid diarrhea.

FSLY vs MDGL — Head-to-Head

Bigger by revenue
MDGL
MDGL
1.9× larger
MDGL
$321.1M
$172.6M
FSLY
Growing faster (revenue YoY)
MDGL
MDGL
+188.0% gap
MDGL
210.8%
22.8%
FSLY
Higher net margin
FSLY
FSLY
9.3% more per $
FSLY
-9.0%
-18.2%
MDGL
More free cash flow
FSLY
FSLY
$146.1M more FCF
FSLY
$12.2M
$-133.8M
MDGL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FSLY
FSLY
MDGL
MDGL
Revenue
$172.6M
$321.1M
Net Profit
$-15.5M
$-58.6M
Gross Margin
61.4%
Operating Margin
-8.7%
-18.6%
Net Margin
-9.0%
-18.2%
Revenue YoY
22.8%
210.8%
Net Profit YoY
52.9%
1.4%
EPS (diluted)
$-0.10
$-2.55

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FSLY
FSLY
MDGL
MDGL
Q4 25
$172.6M
$321.1M
Q3 25
$158.2M
$287.3M
Q2 25
$148.7M
$212.8M
Q1 25
$144.5M
$137.3M
Q4 24
$140.6M
$103.3M
Q3 24
$137.2M
$62.2M
Q2 24
$132.4M
Q1 24
$133.5M
$0
Net Profit
FSLY
FSLY
MDGL
MDGL
Q4 25
$-15.5M
$-58.6M
Q3 25
$-29.5M
$-114.2M
Q2 25
$-37.5M
$-42.3M
Q1 25
$-39.1M
$-73.2M
Q4 24
$-32.9M
$-59.4M
Q3 24
$-38.0M
$-107.0M
Q2 24
$-43.7M
Q1 24
$-43.4M
$-147.5M
Gross Margin
FSLY
FSLY
MDGL
MDGL
Q4 25
61.4%
Q3 25
58.4%
Q2 25
54.5%
Q1 25
53.2%
96.7%
Q4 24
53.4%
Q3 24
54.5%
Q2 24
55.1%
Q1 24
54.8%
Operating Margin
FSLY
FSLY
MDGL
MDGL
Q4 25
-8.7%
-18.6%
Q3 25
-18.2%
-39.7%
Q2 25
-24.8%
-22.2%
Q1 25
-26.4%
-57.8%
Q4 24
-24.4%
-64.8%
Q3 24
-29.6%
-187.1%
Q2 24
-35.3%
Q1 24
-34.6%
Net Margin
FSLY
FSLY
MDGL
MDGL
Q4 25
-9.0%
-18.2%
Q3 25
-18.6%
-39.8%
Q2 25
-25.2%
-19.9%
Q1 25
-27.1%
-53.4%
Q4 24
-23.4%
-57.5%
Q3 24
-27.7%
-172.0%
Q2 24
-33.0%
Q1 24
-32.5%
EPS (diluted)
FSLY
FSLY
MDGL
MDGL
Q4 25
$-0.10
$-2.55
Q3 25
$-0.20
$-5.08
Q2 25
$-0.26
$-1.90
Q1 25
$-0.27
$-3.32
Q4 24
$-0.23
$-2.50
Q3 24
$-0.27
$-4.92
Q2 24
$-0.32
Q1 24
$-0.32
$-7.38

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FSLY
FSLY
MDGL
MDGL
Cash + ST InvestmentsLiquidity on hand
$361.8M
$198.7M
Total DebtLower is stronger
$339.9M
Stockholders' EquityBook value
$929.6M
$602.7M
Total Assets
$1.5B
$1.3B
Debt / EquityLower = less leverage
0.56×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FSLY
FSLY
MDGL
MDGL
Q4 25
$361.8M
$198.7M
Q3 25
$342.9M
$295.7M
Q2 25
$321.2M
$186.2M
Q1 25
$307.3M
$183.6M
Q4 24
$295.9M
$100.0M
Q3 24
$308.2M
$232.7M
Q2 24
$311.8M
Q1 24
$329.5M
$622.5M
Total Debt
FSLY
FSLY
MDGL
MDGL
Q4 25
$339.9M
Q3 25
$339.8M
Q2 25
$118.4M
Q1 25
$118.0M
Q4 24
$117.6M
Q3 24
$117.1M
Q2 24
Q1 24
$116.1M
Stockholders' Equity
FSLY
FSLY
MDGL
MDGL
Q4 25
$929.6M
$602.7M
Q3 25
$937.0M
$625.7M
Q2 25
$942.6M
$696.0M
Q1 25
$957.0M
$710.6M
Q4 24
$965.3M
$754.4M
Q3 24
$969.5M
$777.2M
Q2 24
$981.2M
Q1 24
$991.8M
$850.8M
Total Assets
FSLY
FSLY
MDGL
MDGL
Q4 25
$1.5B
$1.3B
Q3 25
$1.5B
$1.4B
Q2 25
$1.5B
$1.0B
Q1 25
$1.4B
$996.6M
Q4 24
$1.5B
$1.0B
Q3 24
$1.5B
$1.1B
Q2 24
$1.5B
Q1 24
$1.5B
$1.1B
Debt / Equity
FSLY
FSLY
MDGL
MDGL
Q4 25
0.56×
Q3 25
0.54×
Q2 25
0.17×
Q1 25
0.17×
Q4 24
0.16×
Q3 24
0.15×
Q2 24
Q1 24
0.14×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FSLY
FSLY
MDGL
MDGL
Operating Cash FlowLast quarter
$22.4M
$-133.5M
Free Cash FlowOCF − Capex
$12.2M
$-133.8M
FCF MarginFCF / Revenue
7.1%
-41.7%
Capex IntensityCapex / Revenue
5.9%
0.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$65.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FSLY
FSLY
MDGL
MDGL
Q4 25
$22.4M
$-133.5M
Q3 25
$28.9M
$79.8M
Q2 25
$25.8M
$-47.1M
Q1 25
$17.3M
$-88.9M
Q4 24
$5.2M
$-104.5M
Q3 24
$5.0M
$-67.0M
Q2 24
$-4.9M
Q1 24
$11.1M
$-149.2M
Free Cash Flow
FSLY
FSLY
MDGL
MDGL
Q4 25
$12.2M
$-133.8M
Q3 25
$22.9M
$79.0M
Q2 25
$15.9M
Q1 25
$14.7M
Q4 24
$251.0K
$-104.7M
Q3 24
$3.0M
$-67.8M
Q2 24
$-6.7M
Q1 24
$9.5M
$-149.5M
FCF Margin
FSLY
FSLY
MDGL
MDGL
Q4 25
7.1%
-41.7%
Q3 25
14.5%
27.5%
Q2 25
10.7%
Q1 25
10.2%
Q4 24
0.2%
-101.3%
Q3 24
2.2%
-109.0%
Q2 24
-5.1%
Q1 24
7.1%
Capex Intensity
FSLY
FSLY
MDGL
MDGL
Q4 25
5.9%
0.1%
Q3 25
3.8%
0.3%
Q2 25
6.6%
0.0%
Q1 25
1.8%
0.0%
Q4 24
3.5%
0.2%
Q3 24
1.5%
1.3%
Q2 24
1.3%
Q1 24
1.2%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FSLY
FSLY

Network Services$130.8M76%
Security$35.4M21%
Other$6.4M4%

MDGL
MDGL

Rebates Customer Fees Credits Co Pay Assistance And Other$208.5M65%
Other$76.0M24%
Chargebacks Discounts For Prompt Pay And Other Allowances$36.6M11%

Related Comparisons